Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease whose management is complex and requires open communication amongst a multidisciplinary care team. It has a high rate of relapse, with up to 40 percent of patients relapsing within the first two years after primary treatment. Management of a patient with DLBCL begins with prognostic evaluation of the disease and assessing the potential adverse effects of treatments. It should be followed by evaluations of physical, physiological, cognitive, and socio-economic status of the patient. When considering treatment options, the patient should be engaged to share their expectations and goals related to disease control and quality of life.
CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.
“It’s important to listen for meaning when talking with patients and caregivers who are undergoing cancer treatments for diffuse large b-cell lymphoma and incorporating that into the care plan.”
“Need to validate the patient perspective.”
“Shared decision-making is a two-way conversation.”
Robin Atkins, RN, OCN
Symptom Triage Nurse
Virginia Oncology Associates
Norfolk, Virginia
Resources:
Cancer Support Community
Leukemia & Lymphoma Society
This project is supported by AbbVie/Genmab and Genentech.
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain